NCT03523221View on ClinicalTrials.gov

Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis

PHASE1RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Anaphylaxis
Interventions
DRUG

Dexamethasone Oral

use of one dose of Dexamethasone orally.or placebo in addition to regular treatment of anaphylaxis

Trial Locations (1)

3050

RECRUITING

Hamad Medical Corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY